Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-100
SponsorThe University of Texas Medical Branch, Galveston
About this trial
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Eligibility criteria
Qualifiers
Age ≥18 years.
Diagnosed with aneurysmal SAH, Hunt and Hess Grades 1-2.
Consent to study procedures and follow-up evaluations.
Disqualifiers
Known allergies to lidocaine or steroids.
Arteriovenous malformations.
Dural Arteriovenous Fistulas.
Other significant intracranial pathologies.
Trial design
Treatments tested in this trial
- Lidocaine
- Lidocaine and Dexamethasone
Treatment groups
15 Participants
are divided into 3 treatment groupsLocations
1University of Texas Medical Branch, Galveston77555-0158, GalvestonTexas, United States
Sponsors and collaborators
The University of Texas Medical Branch, Galveston
Lead sponsor
Source ClinicalTrials.gov